Acute aortic syndrome
Conditions
Interventions
The enhanced conservative treatment group:None
The conventional conservative treatment group:None
Sponsors
Beijing Anzhen Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age>=18 years; 2. First diagnosis of AAS in both centers; 3. Patients require conservative treatment for various reasons.
Exclusion criteria
Exclusion criteria: 1. Age< 18 years old; 2. Patients who have undergone aortic surgery for AAS in the past; 3. Combined with malignant tumors; 4. Combined with autoimmune diseases; 5. Patients who undergo surgical treatment in the acute period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Echocardiography;Aortic CTA;Prothrombin Time;Activated Partial Thromboplastin Time;Fibrinogen;D-Dimer;C-Reactive Protein;White Blood Cell Count;Absolute Lymphocyte Count;Absolute Neutrophil Count;Neutrophil-to-Lymphocyte Ratio;Platelet-to-Lymphocyte Ratio;Hemoglobin;Platelet Count;B-type Natriuretic Peptide;N-terminal pro-B-type Natriuretic Peptide;Creatine Kinase;Lactate Dehydrogenase;Creatine Kinase-MB Isoenzyme;High-sensitivity Troponin I;Myoglobin;Alanine Aminotransferase;Total Protein;Albumin;Total Bilirubin;Direct Bilirubin;Serum Creatinine;Uric Acid;Estimated Glomerular Filtration Rate (Creatinine-based);Glucose;Potential of Hydrogen (pH);Partial Pressure of Carbon Dioxide in Arterial Blood;Partial Pressure of Oxygen in Arterial Blood;Lactate;Bicarbonate (Plasma);Thyroid Stimulating Hormone;Free Triiodothyronine;Free Thyroxine;Total Triiodothyronine;Total Thyroxine;Thyroid Peroxidase Antibodies;Thyroglobulin Antibodies; | — |
Countries
China
Contacts
Public ContactHongjia Zhang
Beijing Anzhen Hospital Affiliated to Capital Medical University
Outcome results
None listed